Advances in extracellular vesicles for the diagnosis and treatment of corneal and ocular surface diseases
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

Weifang Science and Technology Development Plan Project(No. 2025ZJ1121, 2023YX067, 2025RKX060)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Extracellular vesicles(EVs)are nanoscale membrane vesicles released by cells that carry bioactive molecules such as proteins and nucleic acids. They play a key role in intercellular communication. In recent years, they have shown significant potential in the diagnosis and treatment of corneal and ocular surface diseases. As diagnostic biomarkers, EVs derived from tears or other sources can reflect disease-specific characteristics, providing a basis for the early disease detection. In terms of therapy, mesenchymal stem cells(MSCs)-derived EVs deliver miRNAs to modulate inflammatory pathways, promote corneal epithelial repair, and inhibit fibrosis. Furthermore, as natural drug vehicles, EVs enable precise delivery of therapeutic agents and promote corneal wound healing. This review systematically summarizes the recent research advances in the application of EVs in the field.

    Reference
    Related
    Cited by
Get Citation

Zhang Zhihao, Wang Jiahao, Diao Qihang, et al. Advances in extracellular vesicles for the diagnosis and treatment of corneal and ocular surface diseases. Guoji Yanke Zazhi( Int Eye Sci) 2026;26(8):1365-1370

Copy
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:January 19,2026
  • Revised:June 15,2026
  • Adopted:
  • Online: July 16,2026
  • Published: